NAMPT and Parkinson disease: A study has revealed that elevated levels of IL-6 and TNF-α in Parkinson’s disease (PD) patients, along with alterations in visfatin and progranulin levels between PD patients with and without dyskinesia, indicate significant changes in inflammatory biomarkers and adipokines in PD [36].